Karen Firestone - Mar 16, 2023 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role: Director
Signature: /s/ Joshua B. Cohen, as Attorney in Fact
Stock symbol: AMLX
Transactions as of: Mar 16, 2023
Transactions value $: $0
Form type: 3
Date filed: 3/20/2023, 08:09 PM
Next filing: Jun 12, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney